Nanophase Tech Stock Price, News & Analysis

Nanophase Technologies Corporation (OTCQB: NANX) reported record Q2 revenue of $11.2 million, a 58% increase from $7.1 million in 2021. The Solésence division contributed significantly, achieving $7.1 million in revenue, up 58% YOY, while Personal Care Ingredients surged 86% to $3.3 million. The company has launched over 40 new products this quarter and consolidated its warehousing for better efficiency. With a focus on operational improvements and maintaining growth, Nanophase emphasizes high market demand and product differentiation.

Nanophase Technologies Corporation (OTCQB: NANX) will release its Second Quarter 2022 financial news after the market closes on August 17, 2022. An investor conference call is scheduled for August 18, 2022, at 10:00 a.m. CDT to discuss the financial results and provide a business update. The call will feature President & CEO Jess Jankowski and COO Kevin Cureton. As a leader in minerals-based health care solutions, Nanophase focuses on innovations that protect skin and aid in medical diagnostics.

Solésence Beauty Science announced the receipt of a patent in Korea for its innovative Kleair™ technology, enhancing the effectiveness of zinc oxide in mineral sunscreens. This patented formulation improves UV blocking performance and aesthetic appeal, making it suitable for diverse skin tones. The patent, granted to parent company Nanophase Technologies, covers the use of Kleair™ in various product types including creams, gels, and sprays. This innovation aims to enhance skin health and aligns with global health interests by providing superior protection against UV damage.

Nanophase Technologies Corporation (OTCQB: NANX) reported a record $8.2 million in Q1 2022 revenue, a 15% increase from $7.1 million in Q1 2021. Key highlights include a 29% YOY rise in Solésence revenue and a 70% increase in Active Pharmaceutical Ingredients sales. The company plans to exceed $40 million in revenue for 2022, supported by strong demand and 24 million in open orders. However, production constraints due to staffing issues pose challenges. The addition of 30 new team members aims to enhance operational capacity and support growth.

Nanophase Technologies Corporation (OTCQB: NANX) will release its First Quarter 2022 financial results on May 11, 2022, after market close. An investor conference call is scheduled for May 12, 2022, at 10:00 a.m. CDT, led by President & CEO Jess Jankowski and COO Kevin Cureton. The call can be accessed via dial-in or on the company's website. Nanophase specializes in minerals-based healthcare solutions, focusing on products that protect skin and aid in medical diagnostics.

Nanophase Technologies Corporation (NANX) reported a record 70% year-over-year revenue growth, totaling $29.5 million for 2021. Solésence revenue soared by 170%, while Active Pharmaceutical Ingredients (API) sales grew by 40%. Despite these gains, the company faced operational challenges, including labor shortages and supply chain issues, which affected Q4 profitability. The company is focused on expanding its infrastructure to handle increased demand, recently leasing a new 260,000 sq. ft. facility. Expectations for Q1 2022 revenue are above $7 million, with ongoing partnerships and product launches.

Nanophase Technologies Corporation (OTCQB: NANX) announced it will release its fourth quarter and full year 2021 financial results after market close on March 31, 2022. An investor conference call is scheduled for April 5, 2022, at 10:00 a.m. CDT, to discuss these results and provide further updates. The call will feature President & CEO Jess Jankowski and COO Kevin Cureton. Participants can join the call via U.S. dial-in at 877-312-8776 or international at 408-774-4007. Access to the call will also be available through their website.

Nanophase Technologies Corporation (OTCQB: NANX) has announced the appointment of Ed Sieracki as Vice President of Brand Partnerships and Jennifer Bayon as Vice President of Licensing and Retail Partnerships. These roles aim to enhance customer success and growth among brand and retail partners in response to the increasing demand for Solésence products. Sieracki brings extensive experience from Minerals Technologies Inc., while Bayon has a successful track record from Paris Presents Incorporated. The company has also expanded its team to bolster client service and ongoing GMP efforts.